FDA 483 - Phi Sciences - August 22, 2025

An FDA inspection of Phi Sciences, an own label distributor in Cottonwood, AZ, revealed a failure to follow written procedures for holding and distribution operations. The firm did not maintain required records, including trailer inspection documents and Bills of Lading, for outgoing dietary supplement shipments. This indicates a significant lapse in adherence to established operational protocols.